Chris Sander
Millennium Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chris Sander.
Nature Structural & Molecular Biology | 2001
Dennis Vitkup; Eugene Melamud; John Moult; Chris Sander
Structural genomics has the goal of obtaining useful, three-dimensional models of all proteins by a combination of experimental structure determination and comparative model building. We evaluate different strategies for optimizing information return on effort. The strategy that maximizes structural coverage requires about seven times fewer structure determinations compared with the strategy in which targets are selected at random. With a choice of reasonable model quality and the goal of 90% coverage, we extrapolate the estimate of the total effort of structural genomics. It would take ∼16,000 carefully selected structure determinations to construct useful atomic models for the vast majority of all proteins. In practice, unless there is global coordination of target selection, the total effort will likely increase by a factor of three. The task can be accomplished within a decade provided that selection of targets is highly coordinated and significant funding is available.
Journal of Biopharmaceutical Statistics | 2004
Joël R. Pradines; Laura A. Rudolph-Owen; John Joseph Hunter; Patrick J. LeRoy; Michael P. Cary; Robert Coopersmith; Vlado Dancik; Yelena Eltsefon; Victor Farutin; Christophe Leroy; Jonathan Rees; David Rose; Steve Rowley; Alan Ruttenberg; Patrick Wieghardt; Chris Sander; Christian Reich
Abstract We present a new computational method for identifying regulated pathway components in transcript profiling (TP) experiments by evaluating transcriptional activity in the context of known biological pathways. We construct a graph representing thousands of protein functional relationships by integrating knowledge from public databases and review articles. We use the notion of distance in a graph to define pathway neighborhoods. The pathways perturbed in an experiment are then identified as the subgraph induced by the genes, referred to as activity centers, having significant density of transcriptional activity in their functional neighborhoods. We illustrate the predictive power of this approach by performing and analyzing an experiment of TP53 overexpression in NCI-H125 cells. The detected activity centers are in agreement with the known TP53 activation effects and our independent experimental results. We also apply the method to a serum starvation experiment using HEY cells and investigate the predicted activity of the transcription factor MYC. Finally, we discuss interesting properties of the activity center approach and its possible applications beyond the comparison of two experiments.
Science | 2000
Chris Sander
Bioinformatics | 2000
Vasilis J. Promponas; Anton J. Enright; Sophia Tsoka; David P. Kreil; Christophe Leroy; Stavros J. Hamodrakas; Chris Sander; Christos A. Ouzounis
WWW-publication | 1997
Burkhard Rost; Reinhard Schneider; Chris Sander
Archive | 2016
Alfonso Valencia; Emil F. PAld; Chris Sander
Archive | 1997
Terry Gaasterland; Peter D. Karp; Kevin Karplus; Christos Ouzounis; Chris Sander; Alfonso Valencia
Supercomputer 96 : Anwendungen, Architekturen, Trends | 1996
Reinhard Schneider; Georg Casari; Antoine de Daruvar; P. Bremer; M. Schlenkrich; R. Mercille; H. Vollhardt; Chris Sander
Statustagung des BMBF, HPSC 95, Stand und Perspektiven des Parallelen Höchstleistungsrechnens und seiner Anwendungen | 1995
Reinhard Schneider; Georg Casari; Chris Sander
Archive | 1994
Uwe Goebel; Chris Sander; Reinhard Schneider; Alfonso Valencia